Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine for Refractory Hypotension in ICU
NCT01531959Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2012
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of midodrine in hypotension, sponsored by Massachusetts General Hospital. Started Apr 2012; status: completed.
02
Drugs
midodrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT01531959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01531959.